Evaluation of substance use in Izmir during the COVID-19 pandemic

dc.authoridAYDOGDU, Melike/0000-0002-6324-0234
dc.authoridCan, Özge/0000-0003-3220-5994
dc.authoridAslan, Rukiye/0000-0002-4012-3684
dc.authoridAltunci, Yusuf Ali/0000-0002-4803-5419
dc.authorscopusid57205115361
dc.authorscopusid57222385046
dc.authorscopusid57190797632
dc.authorscopusid16306382400
dc.authorscopusid24801922600
dc.authorwosidAYDOGDU, Melike/W-2368-2017
dc.authorwosidCan, Özge/GVS-4068-2022
dc.authorwosidAslan, Rukiye/W-2331-2017
dc.contributor.authorAydogdu, Melike
dc.contributor.authorAslan, Rukiye
dc.contributor.authorCan, Ozge
dc.contributor.authorAltunci, Yusuf Ali
dc.contributor.authorAkgur, Serap Annette
dc.date.accessioned2023-01-12T19:59:48Z
dc.date.available2023-01-12T19:59:48Z
dc.date.issued2022
dc.departmentN/A/Departmenten_US
dc.description.abstractBackground: Substance use can vary in extraordinary periods, such as natural disasters and epidemics. This study scrutinized the toxicological test results of the people who used different types of substances during the 2020 COVID-19 pandemic period in Izmir. Methods: Due to the COVID-19 outbreak, extreme security measures were implemented in March, April, and May of 2020, and the lockdown was imposed at different levels. The patients who were urine tested for illegal substances were also investigated from the point of the socio-demographic characteristics and clinical data. Results: Thirty-six percent of the cases (n = 32) were positive for illegal substances in urinalysis. These substances were: 60% (n = 12) amphetamine-type stimulants (ATS), 20% (n = 4) benzodiazepine, 10% (n = 2) cannabis, 5% (n = 1) buprenorphine, 5% (n = 1) cocaine. Multiple substance use observed in 12 cases. Conclusions: When the pandemic period data were compared with the previous years, the drug test positive rate in the same periods of 2017 and 2018 was 25.9% and 23.9%, respectively. However, this rate increased to 36% during the pandemic period in 2020. In 2017 and 2018, cannabis was the most frequently found substance in the urine on testing with the rate of 41.5% (n = 184) and 50.8% (n = 219), respectively, it was ATS with 60% (n = 2) in 2020.en_US
dc.identifier.doi10.1080/14659891.2021.1983045
dc.identifier.endpage635en_US
dc.identifier.issn1465-9891
dc.identifier.issn1475-9942
dc.identifier.issn1465-9891en_US
dc.identifier.issn1475-9942en_US
dc.identifier.issue6en_US
dc.identifier.scopus2-s2.0-85116474955en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage629en_US
dc.identifier.urihttps://doi.org/10.1080/14659891.2021.1983045
dc.identifier.urihttps://hdl.handle.net/11454/77236
dc.identifier.volume27en_US
dc.identifier.wosWOS:000704253400001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherTaylor & Francis Incen_US
dc.relation.ispartofJournal Of Substance Useen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectPandemicen_US
dc.subjectsubstance useen_US
dc.subjectdrug analysisen_US
dc.titleEvaluation of substance use in Izmir during the COVID-19 pandemicen_US
dc.typeArticleen_US

Dosyalar